Viewpoint: Assessing Mindfulness-based Cognitive Therapy For Cancer Pain
View web version
Feature
Q&A With Dana Carroll, PhD, Highlights CRISPR's Growing Role in Genome Editing
By
In this question-and-answer session, CTA asked Dr Carroll about CRISPR-Cas9, the state of the science of genome editing, and its implications for oncology.
Most Popular
Combination Immunotherapy Promising for Treatment of Renal Cell Carcinoma
By
Viewpoint
Assessing Mindfulness-based Cognitive Therapy For Cancer Pain
By
Latest News
Response Rate Similar Between Low- and Standard-dose Ponatinib
Imatinib Less Beneficial for Patients With CML in Accelerated Phase
Ibrutinib Linked With Favorable Survival, High Response Rate in CLL

Want to receive emails specific to your profession and specialty? Click here to complete your profile.





Subscribe
If you were sent this by a colleague and wish to subscribe to Weekly highlights, please click here.

Unsubscribe
To unsubscribe from the Weekly Highlights click here.
To manage your entire Cancer Therapy Advisor profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All Cancer Therapy Advisor newsletters are sent from the domain "email.cancertherapyadvisor.com". When configuring e-mail or spam filter rules, please use this domain name.

© 2016 Haymarket Media Inc
275 7th Avenue, 10th Floor
New York, NY 10001